Stocks & Investing
Stocks and InvestingStocks and Investing 
Tue, August 23, 2011
DRUG MANUFACTURERS/OT Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
August 23, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring the top most highly correlated DRUG MANUFACTURERS/OT stocks and the majority have fired a Buy signal as of today. SUCAMPO PHARMACEUTICALS-CL A (NASDAQ:SCMP), SPDR S&P BIOTECH ETF (NYSE:XBI), QUIDEL CORPORATION (NASDAQ:QDEL), USANA HEALTH SCIENCES INC (NYSE:USNA), WATSON PHARMACEUTICALS INC (NYSE:WPI), ALLOS THERAPEUTICS INC (NASDAQ:ALTH) are all expected to be Up as the top stocks in the sector have fired Buy signals. Group rotation is a phenomenon where institutions exert buying or selling pressure in an industry group, pushing prices of the group higher or higher relative to the general market. An industry can often lead or lag the market, and the most highly correlated stocks (mirror closest to the overall move in that group) usually move in unison. The technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The chart below displays the correlation, beta and relative strength of the top most highly correlated stocks in the highlighted industry group:
Symbol Company Correlation Beta RelStr Sector
SCMP SUCAMPO PHARMACEUTICALS-CL A 0.43 0.77 0.82 DRUG MANUFACTURERS/OT
XBI SPDR S&P BIOTECH ETF 0.94 0.75 1 BIOTECHNOLOGY
QDEL QUIDEL CORPORATION 0.46 0.63 1.01 DIAGNOSTIC SUBSTANCES
USNA USANA HEALTH SCIENCES INC 0.37 0.99 0.95 DRUG RELATED PRODUCTS
WPI WATSON PHARMACEUTICALS INC 0.78 0.39 1 DRUGS - GENERIC
ALTH ALLOS THERAPEUTICS INC 0.32 0.7 0.9 DRUG MANUFACTURERS/OT
We automatically calculate correlation to help find the stocks that most closely match their groups movement and generate powerful group consensus trading signals to profit from the herd mentality. When multiple stocks in a group turn at the same time and the rotation of that group is confirmed, an explosive move typically occurs. Correlation measures the tendency for a symbol to move in unison with the group, beta measures the amount the symbol is expected to move relative to the group and relative strength looks back at the recent past to show how the stock has been moving relative to the group.
SUCAMPO PHARMACEUTICALS-CL A (NASDAQ:SCMP) - Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs based on prostones primarily in the Americas, Europe, and Asia. It offers prostone-based compounds for the treatment of gastrointestinal, vascular, respiratory, and central nervous system diseases and disorders. The company primarily markets Amitiza for the treatment of chronic idiopathic constipation in adults, as well as for irritable bowel syndrome with constipation in adult women. It also offers Rescula (unoprostone isopropyl) for the treatment of open-angle glaucoma and ocular hypertension. In addition, the company is developing Amitiza for the treatment of opioid-induced bowel dysfunction, which completed two Phase III clinical trials; Cobiprostone for the prevention of non-steroidal anti-inflammatory drug induced ulcers, which completed a Phase IIa clinical trial; SPI-017, a Phase I clinical trial product, for the treatment of Peripheral arterial disease; and SPI-3608 for the treatment of spinal stenosis, which is under preclinical trial. Additionally, it is conducting a preclinical trial of Rescula for dry age related macular degeneration; and preclinical trials of Cobiprostone for the treatment of chronic obstructive pulmonary disease and wound healing. Sucampo Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
SPDR S&P BIOTECH ETF (NYSE:XBI) - SPDR BIOTECH ETF
QUIDEL CORPORATION (NASDAQ:QDEL) - Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of diagnostic testing solutions for applications primarily in infectious diseases, and reproductive and womens health. It provides point-of-care and other diagnostic tests under the QuickVue, QuickVue+, Quidel, and MicroVue brand names. The company offers products for infectious diseases, such as Influenza, Group A Strep, and Respiratory Syncitial Virus test; and for reproductive and women's health, including pregnancy, Chlamydia trachomatis, and Bone Health. It also provides Immunoassay fecal occult blood test used to detect the presence of blood in stool specimens; and Helicobacter pylori test, a serological test to measure antibodies circulating in the blood caused by the immune response to the H. pylori bacterium. In addition, the company offers veterinary products; and clinical laboratory and research tests that are used in the measurement of circulating immune complexes, complement deficiencies, and complement activation. Quidel Corporation sells its products to professionals for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, and wellness screening centers through a network of national and regional distributors, and a direct sales force in the United States, as well as through distributor arrangements primarily in Japan, Europe, and the Middle East. The company was founded in 1979 and is based in San Diego, California.
USANA HEALTH SCIENCES INC (NYSE:USNA) - USANA Health Sciences, Inc. engages in the development, manufacture, and sale of nutritional and personal care products in North America and the Asia Pacific. The company offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamins and mineral supplements that provide a foundation of nutrition for various age groups; optimizers, which are targeted supplements that support cardiovascular health, skeletal/structural health, and digestive health; and macro-optimizers comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense product line includes personal care products that support healthy skin and hair. These products include perfecting essence, gentle daily cleanser, hydrating toner, daytime protective emulsion, eye nourisher, night renewal, serum intensive, rice bran polisher, creme masque, revitalizing shampoo, nourishing conditioner, firming body nourisher, energizing shower gel, and intensive hand therapy. USANA Health Sciences also develops and sells resource materials and sales tools, including product brochures and business forms; reprints of other commercial publications; and contracts with authors and publishers to produce or provide books, tapes, and other items that deal with health topics and personal motivation to assist its associates. The company distributes its products through a network marketing system of organized independent distributors. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
WATSON PHARMACEUTICALS INC (NYSE:WPI) - Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacturing, marketing, sale, and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on urology and women's health in the United States and internationally. The company offers its products for therapeutic categories, such as central nervous system, hormones and synthetic substitutes, cardiovascular, nephrology, and gastrointestinal. It operates in three segments: Global Generic, Global Brand, and Distribution. The Global Generic segment develops, manufactures, markets, sells, and distributes generic products, as well as distributes generic versions of third parties brand products. This segment offers various dosage forms, such as oral solids, transdermals, injectables, inhalation products, and transmucosals for indications, including pregnancy prevention, pain management, depression, hypertension, and smoking cessation. The Global Brand segment includes its promoted urology products, such as Rapaflo, Gelnique, and Trelstar; and various non-promoted products. The Distribution segment distributes generic and certain select brand pharmaceutical products manufactured by third parties, as well as by the company, primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians offices. The company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order, government agencies, and managed healthcare providers, such as health maintenance organizations and other institutions. It has a development and license agreement with Natco Pharma Limited to develop and commercialize lenalidomide tablets. Watson Pharmaceuticals was founded in 1983 and is based in Corona, California.
ALLOS THERAPEUTICS INC (NASDAQ:ALTH) - Allos Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing anti-cancer therapeutics. It is developing FOLOTYN (pralatrexate injection), a folate analogue metabolic inhibitor, for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. The company is also developing FOLOTYN as a single agent and in combination therapy regimens in various hematologic malignancies and solid tumor indications, including stage IV breast cancer and recurrent/metastatic head and neck cancer. It sells FOLOTYN to pharmaceutical wholesale distributors who then resell it to patients respective health care providers. The company was formerly known as HemoTech Sciences, Inc. and changed its name to Allos Therapeutics, Inc. in October 1994. Allos Therapeutics, Inc. was founded in 1992 and is headquartered in Westminster, Colorado.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net